cbdMD, Inc. (YCBD)

US — Healthcare Sector
Peers: CVSI  CWBHF  AKAN  BFRI  GNLN  VFF 

Automate Your Wheel Strategy on YCBD

With Tiblio's Option Bot, you can configure your own wheel strategy including YCBD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol YCBD
  • Rev/Share 2.5171
  • Book/Share -51.4053
  • PB 0.0109
  • Debt/Equity 1.1189
  • CurrentRatio 0.0
  • ROIC 0.8795

 

  • MktCap 8284821.0
  • FreeCF/Share -88.2532
  • PFCF -0.0121
  • PE -6.2449
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.0069

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
YCBD
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

cbdMD, Inc. (NYSE:YCBD ) Q2 2025 Earnings Conference Call May 15, 2025 4:20 PM ET Company Participants Brad Whitford – Chief Accounting Officer Ronan Kennedy – Chief Executive Officer and Chief Financial Officer Conference Call Participants Tom McGovern – Maxim Group Adam Waldo – Lismore Partners Operator Good afternoon. Welcome to the cbdMD, Inc. Conference Call to discuss results for their Second Quarter Fiscal 2025 period ending March 25, 2025.

Read More
image for news cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
YCBD
Published: May 09, 2025 by: Newsfile Corp
Sentiment: Neutral

Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.

Read More
image for news cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
YCBD
Published: May 07, 2025 by: Newsfile Corp
Sentiment: Neutral

Charlotte, North Carolina--(Newsfile Corp. - May 7, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is now proud to be distributed by Carolina Premium Beverage, serving Charlotte NC and surrounding counties. Starting in May, consumers will be able to find Oasis on shelves across North Carolina.

Read More
image for news Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion
YCBD
Published: April 21, 2025 by: Newsfile Corp
Sentiment: Neutral

Charlotte, North Carolina--(Newsfile Corp. - April 21, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD PRA) (the "Company") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, announced today that the automatic conversion (the "Conversion") of shares of its 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock"), into the Company's Common Stock, $0.001 par value per share (the "Common Stock") will be effective at 4:01 p.m. Eastern Time on May 6, 2025 (the …

Read More
image for news cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion

About cbdMD, Inc. (YCBD)

  • IPO Date 2017-11-17
  • Website https://www.cbdmd.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO T. Ronan Kennedy
  • Employees 42

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.